All the news from the past week.
Missed a story over the past week? As per usual, you can catch up with our regular roundup.
Philippe Vercruyssen joins Ovizio
Vercruyssen will serve as executive chairman and managing director at the Université Libre de Bruxelles spin-out.
Sussex Place Ventures launches $51m fund
London Business School’s fund management company will back early-stage technology companies in the UK.
Led by Acadia Woods, the series A will allow the company to further develop its product.
The seed fund will support commercialisation of medical technology developed at Wisconsin University’s School of Medicine and Public Health.
Oxford research shines on renewable energy
Spin-out Oxford PV is hoping to market solar cells using perovskites in three years’ time.
Irish energy provider ESB invests €7m into University College Dublin spin-out Cylon Controls.
Canterbury spin-out Puteko is taking home the award for its augmented reality colouring-in app.
Launched in 1998, the Emergent Technologies fund was initially met with scepticism.
Gates goes bananas for Queensland research
Bill and Miranda Gates Foundation back Queensland’s “super-bananas”.
Schoology makes the grade with $15m
Washington University startup Schoology has closed its series C led by Intel Capital.
The latest round takes the company’s total outside funding to $17.1m
Toronto constructs 11 new ventures
The startups are graduating from the university’s Creative Destruction Lab.
Washington University sequences spin-out
PierianDx will commercialise diagnostic tools for personalised medicine.
Durham spin-out Kromek has secured several new contracts, including one worth $1.45m with the US Defense Threat Reduction Agency.
Nautricity tides project in Canada
Fundy Tidal signs a memorandum of understanding with the Scottish spin-out for a 500kW tidal project.
Whiskey by-products could be used to power current vehicles.
Intelligent Energy emits $1bn flotation
Loughborough’s spin-out is set to float on the London Stock Exchange valued at £615m.
Shares in the spin-out have risen by a quarter on announcement of its latest trial results.
